Inflammation, poststroke depression and statins

International Journal of Stroke

Volumn 6, Issue 6, 2011, Pages 567-568

  Asplund, Kjell ^a   Eriksson, Marie ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; SEROTONIN UPTAKE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

AGE; ANTIINFLAMMATORY ACTIVITY; BRAIN ISCHEMIA; DAILY LIFE ACTIVITY; DEPRESSION; DRUG EFFECT; DRUG USE; FOLLOW UP; GENDER; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; LETTER; MOOD; MOOD DISORDER; PLEIOTROPY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SELF REPORT; STROKE;

ANIMALS; DEPRESSION; HUMANS; INFLAMMATION; STROKE;

EID: 82255192751     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00691.x     Document Type: Letter

References (5)

1. Pascoe MC, Crewther SG, Carey LM, Crewther DP. Inflammation and depression: why post-stroke depression may be the norm and not the exception. Int J Stroke 2011; 6:128-135.
2. Devaraj S, Rogers J, Jialal I. Statins and biomarkers of inflammation. Curr Atherosclerosis Rep 2007; 9:33-41.
3. Asplund K, Hulter Asberg K, Appelros P et al. The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care. Int J Stroke 2011; 6:99-108.
4. Spitzer RL, Williams JB, Kroenke K et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994; 272:1749-1756.
5. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2008: CD003689.